Evidence map›Paper›PMID 42569980›Full record

ArticleJACC. Case reports2026

Inflammatory Pericardial Effusion With Hemorrhagic Conversion in Takotsubo Cardiomyopathy.

Ameer Odeh, Nausheen Akhter, Gokce Deniz Ardor, Mohammed Ruzieh

Abstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ameer OdehFeinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Nausheen AkhterBluhm Cardiovascular Institute, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Gokce Deniz ArdorDepartment of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Mohammed RuziehBluhm Cardiovascular Institute, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. Electronic address: mohammed.ruzieh@nm.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTakotsubo cardiomyopathy (TC) is a reversible stress-induced cardiomyopathy that may be triggered by acute neurologic events. Significant pericardial effusions associated with TC are uncommon, and hemorrhagic transformation is rarely reported. CASE SUMMARY: A 75-year-old woman developed TC after an ischemic stroke and was started on dual antiplatelet therapy (DAPT). Initial transthoracic echocardiogram demonstrated a small pericardial effusion. Six weeks later, she was incidentally found to have a large hemorrhagic pericardial effusion with echocardiographic features of tamponade requiring pericardiocentesis and ultimately a pericardial window. Extensive evaluation for infectious, malignant, and autoimmune etiologies was unrevealing. DISCUSSION: This case highlights a rare progression from TC-associated inflammatory pericardial effusion to a hemorrhagic effusion in the setting of recent DAPT exposure and underscores the complex interaction between neurocardiac stress and bleeding risk. TC may generate an inflammatory milieu involving the pericardium and pleura, increasing the risk of effusions and influencing management, particularly with antithrombotic therapy. TAKE-HOME MESSAGES: TC after acute neurologic injury can be complicated by evolving pericardial effusions that may rarely become hemorrhagic. In patients receiving DAPT, close surveillance may be warranted, as antithrombotic exposure may potentiate clinically significant pericardial bleeding.

Indexed as

antiplateletcardiomyopathyechocardiographypericardial effusionscardiomyopathystroke

Identifiers

PMID42569980
PMCPMC13689858

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.